SCN1A Variants as the Underlying Cause of Genetic Epilepsy with Febrile Seizures Plus in Two Multi-Generational Colombian Families
暂无分享,去创建一个
H. Mefford | D. Nickerson | S. Leal | M. Bamshad | N. Pineda-Trujillo | I. Schrauwen | William Cornejo-Ochoa | T. Bharadwaj | Anushree Acharya | Jaime Carrizosa-Moog | Diana M. Cornejo-Sánchez | Lizeth Marin-Gomez | Pilar Pereira-Gomez | Liz M. Nouel-Saied | University Of Washington Center For Mendelian Geno | Thashi Bharadwaj | N. Pineda‐Trujillo | Nicolas Pineda‐Trujillo | Lizeth Marín-Gómez
[1] Christopher G Chute,et al. The Human Phenotype Ontology in 2021 , 2020, Nucleic Acids Res..
[2] R. Nabbout,et al. Impact of predictive, preventive and precision medicine strategies in epilepsy , 2020, Nature Reviews Neurology.
[3] L. Chertkoff,et al. Molecular diagnosis of epileptic encephalopathy of the first year of life applying a customized gene panel in a group of Argentinean patients , 2020, Epilepsy & Behavior.
[4] L. Kádasi,et al. A Study among the Genotype, Functional Alternations, and Phenotype of 9 SCN1A Mutations in Epilepsy Patients , 2020, Scientific Reports.
[5] S. Berkovic,et al. Genetics of Epilepsy , 2019 .
[6] S. Berkovic,et al. Epilepsy genetics: clinical impacts and biological insights , 2020, The Lancet Neurology.
[7] Ryan L. Collins,et al. The mutational constraint spectrum quantified from variation in 141,456 humans , 2020, Nature.
[8] D. Hampson,et al. Sexually Divergent Mortality and Partial Phenotypic Rescue After Gene Therapy in a Mouse Model of Dravet Syndrome , 2019, Human gene therapy.
[9] S. Schorge,et al. SCN1A variants from bench to bedside—improved clinical prediction from functional characterization , 2019, Human mutation.
[10] Marina C. Gonsales,et al. Multimodal Analysis of SCN1A Missense Variants Improves Interpretation of Clinically Relevant Variants in Dravet Syndrome , 2019, Front. Neurol..
[11] Brian E. Cade,et al. Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program , 2019, Nature.
[12] Gregory M. Cooper,et al. CADD: predicting the deleteriousness of variants throughout the human genome , 2018, Nucleic Acids Res..
[13] Chunlei Liu,et al. ClinVar: improving access to variant interpretations and supporting evidence , 2017, Nucleic Acids Res..
[14] I. Scheffer,et al. Genetic epilepsy with febrile seizures plus , 2017, Neurology.
[15] M. T. Magaña-Torres,et al. Determination of SCN1A genetic variants in Mexican patients with refractory epilepsy and Dravet syndrome. , 2017, Genetics and molecular research : GMR.
[16] J. Sambrook,et al. Isolation of High-Molecular-Weight DNA Using Organic Solvents. , 2017, Cold Spring Harbor protocols.
[17] Edouard Hirsch,et al. ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology , 2017, Epilepsia.
[18] N. Tommerup,et al. Gene Panel Testing in Epileptic Encephalopathies and Familial Epilepsies , 2016, Molecular Syndromology.
[19] Pietro Liò,et al. The BioMart community portal: an innovative alternative to large, centralized data repositories , 2015, Nucleic Acids Res..
[20] H. Rehm,et al. Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.
[21] P. Striano,et al. Rescuable folding defective NaV1.1 (SCN1A) mutants in epilepsy: Properties, occurrence, and novel rescuing strategy with peptides targeted to the endoplasmic reticulum , 2015, Neurobiology of Disease.
[22] J. H. Cross,et al. ILAE Official Report: A practical clinical definition of epilepsy , 2014, Epilepsia.
[23] Lars Feuk,et al. The Database of Genomic Variants: a curated collection of structural variation in the human genome , 2013, Nucleic Acids Res..
[24] Bradley P. Coe,et al. Copy number variation detection and genotyping from exome sequence data , 2012, Genome research.
[25] Helga Thorvaldsdóttir,et al. Integrative Genomics Viewer , 2011, Nature Biotechnology.
[26] Serafim Batzoglou,et al. Identifying a High Fraction of the Human Genome to be under Selective Constraint Using GERP++ , 2010, PLoS Comput. Biol..
[27] Andrew Escayg,et al. Sodium channel SCN1A and epilepsy: Mutations and mechanisms , 2010, Epilepsia.
[28] M. DePristo,et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.
[29] H. Hakonarson,et al. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.
[30] W. Hauser,et al. The descriptive epidemiology of epilepsy—A review , 2009, Epilepsy Research.
[31] Gonçalo R. Abecasis,et al. The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..
[32] Richard Durbin,et al. Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .
[33] Alan F. Scott,et al. McKusick's Online Mendelian Inheritance in Man (OMIM®) , 2008, Nucleic Acids Res..
[34] Aldo Quattrone,et al. Identification of an Nav1.1 sodium channel (SCN1A) loss-of-function mutation associated with familial simple febrile seizures. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[35] G. Bedoya,et al. A novel SCN1A mutation associated with severe GEFS+ in a large South American pedigree , 2005, Seizure.
[36] A. L. Goldin,et al. Generalized epilepsy with febrile seizures plus type 2 mutation W1204R alters voltage-dependent gating of Nav1.1 sodium channels , 2003, Neuroscience.
[37] I. Scheffer,et al. Generalized epilepsy with febrile seizures plus. A genetic disorder with heterogeneous clinical phenotypes. , 1997, Brain : a journal of neurology.